76 episodes

A podcast brought to you by Charlton Morris, where we speak to thought leaders from the markets we serve.

Join in the conversation at cmconversations@charltonmorris.com

CM Conversations Charlton Morris

    • Business

A podcast brought to you by Charlton Morris, where we speak to thought leaders from the markets we serve.

Join in the conversation at cmconversations@charltonmorris.com

    The Future of Catheter Ablations with EP Frontiers CEO, Avi Fischer.

    The Future of Catheter Ablations with EP Frontiers CEO, Avi Fischer.

    In this episode, I talk to Avi Fischer, CEO of innovative Italian medtech start-up, Electrophysiology Frontiers. He discussed the excitement and challenges of heading up a start-up creating a unique catheter ablation product, the first of its kind in the market.

    We discuss the future of cardiac ablation procedures and the innovative devices under development which are set to change the landscape of how we treat A-fib. Whether you're in the device or wider Cardiovascular market, Avi's insight as an ex-physician and successful industry leader is not one to miss!

    If you'd like to get in touch to discuss any points featured in this episode, would like to be a future podcast guest or want to learn more about our CM Medical services; then please email me at james.christopher@medical-cm.com.

    • 17 min
    New Liquid Biopsy Technologies to Know. Part 3 with Dennis Merkle, CEO of Predicine Europe.

    New Liquid Biopsy Technologies to Know. Part 3 with Dennis Merkle, CEO of Predicine Europe.

    In the final part of this three-part episode, Dennis and Adam discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the scenes at Predicine.

    Dennis touches on how to become a legendary company in your market, and what this means in liquid biopsy terms. A truly eye-opening discussion which anyone would be sure to gain something from.

    In parts one and two, we discussed the importance of liquid biopsy for the future oncology market as well as strategies for overcoming barriers when entering new markets. A huge thanks to Dennis for coming on to share his knowledge and experience.

    If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.

    • 15 min
    What are the Key Market Barriers within Liquid Biopsy? Part 2 with Dennis Merkle, CEO of Predicine Europe.

    What are the Key Market Barriers within Liquid Biopsy? Part 2 with Dennis Merkle, CEO of Predicine Europe.

    In part two of this three-part discussion, Adam and Dennis discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering the market.

    Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Discussing the challenges and opportunities he's faced as the CEO of Predicine in Europe.

    This conversation comes in three parts. In part one, the pair discussed the importance of liquid biopsy for the future oncology market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available.

    If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.

    • 19 min
    Why is Liquid Biopsy So Important? Part 1 with Dennis Merkle, CEO of Predicine Europe.

    Why is Liquid Biopsy So Important? Part 1 with Dennis Merkle, CEO of Predicine Europe.

    In the second episode of Diagnostics Digest, Adam speaks to Dennis Merkle, CEO of Europe and Global Head of Biopharma Business for molecular insights company, Predicine. Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Here we jump into a well-rounded discussion on the benefits of liquid biopsy in today's oncology market.

    This conversation comes in three parts. In part two, we delve into crucial barriers within the market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available.

    If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.

    • 24 min
    Sustainable Mining Solutions? Get Your Head in the Cloud.

    Sustainable Mining Solutions? Get Your Head in the Cloud.

    In this episode we speak with Sandeep Sandhu, General Manager of the Americas at RPM Global, about the power of digitisation to help traditional mining practices meet sustainable goals.

    In this discussion, our Associate Director at CM Industrial and specialist recruiter in the global Mining space, Jamie Sheard, discusses the the importance of software and cloud-based technologies as mining solutions, and the role digitisation plays in reaching sustainable goals. RPM Global is an Australian based company, whose recent expansion and success across the Americas is largely attributed to these strategies.

    Whether you’re in the mining technology industry, are interested in ways to adapt business models to meet new sustainability initiatives or are interested in learning about expansion into new territories, there’s something in here for everyone. Enjoy!

    Please get in touch with Jamie at jamie.sheard@industrial-cm.com, if you'd like to discuss the topic and trend in some more detail.

    • 26 min
    Who is paving the way in single-use endoscopy?

    Who is paving the way in single-use endoscopy?

    In this episode I talk to Bassel Rifai, SVP and Chief Marketing Officer at Ambu A/S, a company whose single-use endoscopes are some of the most innovative currently available on the market. Despite potential questions as to its sustainability, the result of COVID makes these products more crucial than ever.

    Bassel touches on these alongside many other interesting topics, including key learnings, challenges and successes Ambu has embraced as a result of a changing market. A hugely engaging personality with some brilliant insight into the market.

    If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Medical services; then please email me at jordan.burgin@medical-cm.com.

    • 22 min

Top Podcasts In Business

Ramsey Network
Ed Mylett
Jocko DEFCOR Network
NPR
Andy Frisella #100to0
Wondery